Biomaterials‐Based Delivery of Therapeutic Antibodies for Cancer Therapy

Considerable breakthroughs in the treatment of malignant tumors using antibody drugs, especially immunomodulating monoclonal antibodies (mAbs), have been made in the past decade. Despite technological advancements in antibody design and manufacture, multiple challenges face antibody‐mediated cancer...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Advanced healthcare materials 2021-06, Vol.10 (11), p.e2002139-n/a
Hauptverfasser:	Ye, Qian‐Ni, Wang, Yue, Shen, Song, Xu, Cong‐Fei, Wang, Jun
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies antibody drugs Anticancer properties Antitumor activity Biocompatibility Biomaterials Biomedical materials Cancer cancer immunotherapy Cancer therapies cancer treatment Cytotoxicity delivery system Drugs Immobilization Monoclonal antibodies Therapy Toxicity Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!